StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) stock

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.80−0.14 (-6.96%)

Close on Nov 18, 2026Market cap $144.72MP/E –Yield –

BridgeBio Oncology Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BridgeBio Oncology Therapeutics's market cap was $205.09M on Nov 11, 2026, against $974.91M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$205.09M-79.3%
2025Dec 31, 2025$991.54M–

More BridgeBio Oncology Therapeutics figures

See a number that looks wrong?